Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.

News | January 09, 2012

January 9, 2012 – A registry that includes every patient in Sweden having percutaneous coronary intervention (PCI)...

News | December 22, 2011

December 22, 2011 ­– Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe...

Technology | December 12, 2011

December 12, 2011 - Boston Scientific recently announced U.S. Food and Drug Administration (FDA) approval for the...

News | December 09, 2011

December 9, 2011 — Abbott announced Thursday the initiation of ABSORB II, the first randomized, controlled, multi-...

News | November 21, 2011

November 21, 2011 — Micell Technologies Inc. announced the release of preliminary data...

News | November 15, 2011

November 15, 2011 – The risk of late stent thrombosis (ST) in the first generation of drug-eluting stents continues...

News | November 15, 2011

November 15, 2011 – A clinical trial that compared the use of drug-eluting balloons (DEB) and bare metal stents (BMS...

News | November 15, 2011

November 15, 2011 — Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were...

News | November 15, 2011

November 15, 2011 — Researchers have found polymer-free amphilimus-eluting stents in de novo coronary artery lesions...

News | November 15, 2011

November 15, 2011 — A new clinical trial is testing the efficacy of rotational atherectomy (or rotablation, a...

News | November 15, 2011

November 15, 2011 — A clinical trial has shown a drug-eluting stent (DES) with a bioabsorbable polymer has...

News | November 14, 2011

November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast...

News | November 14, 2011

November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real...

News | November 11, 2011

November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non-...

News | November 11, 2011

November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human...

Overlay Init